Oramed Pharmaceuticals (ORMP) Total Return Calculator
$10,000 since Dec 2007, with and without reinvesting · data through Oct 2026
$10,000 invested in Oramed Pharmaceuticals (ORMP) ten years ago, at the end of Oct 2016, was worth $6,640 at the end of Oct 2026 with every dividend reinvested: -4.0% a year, against $41,633 in the S&P 500. Since Dec 2007, $10,000 became $14,124 reinvested (1.9% a year), or $15,178 taking the dividends as cash, $2,005 of it paid out along the way.
ORMP became
$14,124
S&P 500: $72,756
Return a year
1.9%
S&P 500: 11.1%
Payouts reinvested
$2,004
bought more shares
Worst drop
-92.2%
S&P 500: -48.2%
$10,000, Dec 2007 to Oct 2026
Payouts reinvested · S&P 500 reinvested
| Year | ORMP total return | Paid out | S&P 500 |
|---|---|---|---|
| 2026 (part) | +54.5% | $772 | +11.7% |
| 2025 | +17.7% | $54 | +17.7% |
| 2024 | +5.1% | $83 | +24.9% |
| 2023 | −80.8% | $71 | +26.2% |
| 2022 | −15.8% | $50 | −18.2% |
| 2021 | +237.0% | $82 | +28.7% |
| 2020 | −17.7% | $58 | +18.3% |
| 2019 | +71.4% | $65 | +31.2% |
| 2018 | −66.6% | $68 | −4.6% |
| 2017 | +46.9% | $54 | +21.7% |
| 2016 | −28.4% | $99 | +12.0% |
| 2015 | +87.5% | $78 | +1.2% |
| 2014 | −70.4% | $63 | +13.5% |
| 2013 | +289.7% | $52 | +32.3% |
| 2012 | +17.9% | $74 | +16.0% |
| 2011 | −6.8% | $67 | +1.9% |
| 2010 | −33.2% | $79 | +15.1% |
| 2009 | +15.4% | $67 | +26.4% |
| 2008 | +49.8% | $69 | −36.8% |
"Paid out" is what your holding received that year. Month-end prices; no costs or taxes.
Key facts: ORMP total return
Data as of · Source: SmarterDividends data
- $10,000 invested in Oramed Pharmaceuticals (ORMP) at the end of Dec 2007, with dividends reinvested, was worth $14,124 at the end of Oct 2026: 1.9% a year, against $72,756 (11.1% a year) in the S&P 500.
- Over the 10 years to Oct 2026, ORMP turned $10,000 into $6,640 with dividends reinvested, -4.0% a year.
- Over the 5 years to Oct 2026, ORMP returned -28.4% a year with dividends reinvested (S&P 500: 12.0%).
- Taking ORMP's dividends as cash instead of reinvesting them, the same $10,000 ended at $15,178, including $2,005 of cash received; reinvesting added $0.
- ORMP's best calendar year in that time was 2013 (289.7%) and its worst 2023 (-80.8%), with dividends reinvested.
Cite this page
SmarterDividends, "Oramed Pharmaceuticals (ORMP) Total Return Calculator," updated Nov 8, 2026, https://smarterdividends.com/stocks/ORMP/total-return
ORMP total return questions
If I invested $10,000 in ORMP 10 years ago, how much would I have?
About $6,640 at the end of Oct 2026, with every dividend reinvested: -4.0% a year. Taking them as cash, you'd have shares worth $6,190 or so plus the cash you received. The same $10,000 in the S&P 500 became $41,633.
What is ORMP's total return since Dec 2007?
41% in total, or 1.9% a year, through Oct 2026 with dividends reinvested. The share price alone rose 32%.
How much of ORMP's return came from dividends?
About 20% of its yearly return since Dec 2007. Reinvesting them, rather than taking cash, left you $0 better off on a $10,000 start.
What was ORMP's worst year?
2023, at -80.8% with dividends reinvested (S&P 500: 26.2%). Its deepest fall from a peak, on month-end values, was -92.2%.
How is total return calculated here?
From month-end prices: the adjusted price counts every dividend reinvested in the month it was paid; the plain price doesn't. The S&P 500 is SPY with its dividends reinvested. No trading costs or taxes.